Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround 
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change 
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease 
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz 
EU Signals Major Shift on 2035 Combustion Engine Ban Amid Auto Industry Pressure 
Union-Aligned Investors Question Amazon, Walmart and Alphabet on Trump Immigration Policies 
Shell M&A Chief Exits After BP Takeover Proposal Rejected 
LG Energy Solution Shares Slide After Ford Cancels EV Battery Supply Deal 
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools 
Citi Appoints Ryan Ellis as Head of Markets Sales for Australia and New Zealand 
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery 
Micron Technology Forecasts Surge in Revenue and Earnings on AI-Driven Memory Demand 
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law 
FDA Says No Black Box Warning Planned for COVID-19 Vaccines Despite Safety Debate 
SUPERFORTUNE Launches AI-Powered Mobile App, Expanding Beyond Web3 Into $392 Billion Metaphysics Market 
Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates 
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation 
WILMINGTON, Del., Sept. 06, 2016 -- Andrews & Springer LLC, a boutique securities class action law firm focused on representing shareholders nationwide, is investigating potential breach of fiduciary duty claims against the Board of Directors of Accuride Corporation (“Accuride” or the “Company”) relating to the sale of the Company to affiliates of private investment firm Crestview Partners (“Crestview”). On September 2, 2016, the two parties announced the signing of a definitive merger agreement pursuant to which Crestview will acquire Accuride in a merger worth $124 million. As a result of the merger, Accuride shareholders are only anticipated to receive $2.58 per share in cash in exchange for each share of Accuride.
Our investigation is looking into whether Accuride’s top executives were conflicted and acted in their own self-interest when approving the merger. According to the Company’s September 2nd announcement, Accuride’s senior management will continue their employment post-merger: “President and CEO Rick Dauch and the members of the Accuride Leadership Team will continue to lead the business after the transaction closes.” Additionally, we are looking into the suspicious timing of Accuride’s recently announced agreement to sell its Brillion Iron Works subsidiary to a subsidiary of Metaldyne Performance Group Inc.
If you own shares of Accuride and want to receive additional information and protect your investments free of charge, please visit us at http://www.andrewsspringer.com/cases-investigations/accuride-class-action-investigation or contact Craig J. Springer, Esq. at [email protected], or call toll free at 1-800-423-6013. You may also follow us on LinkedIn – www.linkedin.com/company/andrews-&-springer-llc, Twitter – www.twitter.com/AndrewsSpringer or Facebook - www.facebook.com/AndrewsSpringer for future updates.
Andrews & Springer is a boutique securities class action law firm representing shareholders nationwide who are victims of securities fraud, breaches of fiduciary duty or corporate misconduct. Having formerly defended some of the largest financial institutions in the world, our founding members use their valuable knowledge, experience, and superior skill for the sole purpose of achieving positive results for investors. These traits are the hallmarks of our innovative approach to each case our Firm decides to prosecute. For more information please visit our website at www.andrewsspringer.com. This notice may constitute Attorney Advertising.
Contact: Craig J. Springer, Esq. [email protected] Toll Free: 1-800-423-6013
